Boston Scientific (BSX; Natick, Massachusetts) has made a second equity investment in – and extended its exclusive option to acquire – EndoTex Interventional Systems (Cupertino, California). In addition, Boston Sci has agreed to acquire EndoTex upon the achievement of certain regulatory milestones.